01 1Cipla Ltd.
01 1Tenofovir Disoproxil Succinate
01 1India
TENOFOVIR DISOPROXIL SUCCINATE
NDC Package Code : 53104-7711
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Tenofovir Disoproxil Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenofovir Disoproxil Succinate, including repackagers and relabelers. The FDA regulates Tenofovir Disoproxil Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenofovir Disoproxil Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tenofovir Disoproxil Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tenofovir Disoproxil Succinate supplier is an individual or a company that provides Tenofovir Disoproxil Succinate active pharmaceutical ingredient (API) or Tenofovir Disoproxil Succinate finished formulations upon request. The Tenofovir Disoproxil Succinate suppliers may include Tenofovir Disoproxil Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Tenofovir Disoproxil Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tenofovir Disoproxil Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tenofovir Disoproxil Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tenofovir Disoproxil Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tenofovir Disoproxil Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tenofovir Disoproxil Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tenofovir Disoproxil Succinate suppliers with NDC on PharmaCompass.
We have 1 companies offering Tenofovir Disoproxil Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
